Pages that link to "Q70883299"
Jump to navigation
Jump to search
The following pages link to Decreased potency of MDR-modulators under serum conditions determined by a functional assay (Q70883299):
Displaying 7 items.
- Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933. (Q33183696) (← links)
- Future perspectives for the development of P-glycoprotein modulators (Q40271710) (← links)
- The functional role of P-glycoprotein in the blood-brain barrier (Q41576234) (← links)
- Measurement of basal, substrate induced and total P-glycoprotein activity in bronchoalveolar lavage T-cell subsets (Q42456344) (← links)
- Bioanalysis and preliminary pharmacokinetics of the acridonecarboxamide derivative GF120918 in plasma of mice and humans by ion-pairing reversed-phase high-performance liquid chromatography with fluorescence detection (Q43703559) (← links)
- Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice (Q44879814) (← links)
- The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts (Q73038137) (← links)